Acquired hemolytic anemia — VA Rating Criteria (38 CFR DC 7723)
The VA rates Acquired hemolytic anemia under 38 CFR 38 CFR § 4.117, Diagnostic Code 7723, from 0% to 100% based on the frequency and functional severity of symptoms. The maximum 100% rating requires Requiring a bone marrow transplant or continuous intravenous or immunosuppressive therapy (e.g., prednisone, Cytoxan, azathioprine, or rituximab). Related conditions in the Hematologic body system share this rating framework.
What are the VA rating criteria for Acquired hemolytic anemia?
Asymptomatic
Requiring one course of immunosuppressive therapy per 12-month period
Requiring at least 2 but less than 4 courses of immunosuppressive therapy per 12-month period
Requiring immunosuppressive medication 4 or more times per 12-month period
Requiring a bone marrow transplant or continuous intravenous or immunosuppressive therapy (e.g., prednisone, Cytoxan, azathioprine, or rituximab)
“Requiring at least 2 but less than 4 courses of immunosuppressive therapy per 12-month period”
How does the VA rate Hematologic conditions?
Common Questions About Acquired hemolytic anemia VA Ratings
What is the VA disability rating for Acquired hemolytic anemia?
The VA rates Acquired hemolytic anemia under Diagnostic Code 7723 at the following tiers: 0%, 10%, 30%, 60%, 100%. The minimum 0% rating requires: Asymptomatic. The maximum 100% rating requires: Requiring a bone marrow transplant or continuous intravenous or immunosuppressive therapy (e.g., prednisone, Cytoxan, azathioprine, or rituximab).
What is Diagnostic Code 7723?
Diagnostic Code 7723 is the VA rating identifier for Acquired hemolytic anemia within 38 CFR 38 CFR § 4.117. It defines the specific symptom criteria and percentage thresholds a VA adjudicator uses to assign a disability rating. The diagnostic code is listed on a veteran's rating decision letter.
What is the highest rating for Acquired hemolytic anemia?
The highest schedular rating for Acquired hemolytic anemia under DC 7723 is 100%. This tier requires: Requiring a bone marrow transplant or continuous intravenous or immunosuppressive therapy (e.g., prednisone, Cytoxan, azathioprine, or rituximab). Veterans who cannot secure substantially gainful employment due to Acquired hemolytic anemia alone or in combination with other service-connected conditions may also qualify for TDIU at the 100% compensation rate under 38 CFR § 4.16.
What 38 CFR section governs Acquired hemolytic anemia ratings?
Acquired hemolytic anemia is rated under 38 CFR 38 CFR § 4.117, Diagnostic Code 7723. This section is part of the Schedule for Rating Disabilities (38 CFR Part 4) and can be read in full at the eCFR website.
Which conditions are commonly secondary to Acquired hemolytic anemia?
Secondary conditions caused or aggravated by Acquired hemolytic anemia may be ratable under 38 CFR § 3.310. Veterans should work with a VSO or accredited claims agent to document the medical relationship.
What evidence do I need to establish service connection for Acquired hemolytic anemia?
Service connection for Acquired hemolytic anemia requires three elements: (1) a current diagnosis of the condition, (2) an in-service event, injury, or disease that may have caused or aggravated it, and (3) a medical nexus connecting the current diagnosis to that in-service event. A nexus letter from a treating physician or independent medical examiner is the most reliable nexus evidence. C&P exam findings can also establish nexus if adequately documented.
Get a Personalized Rating Analysis
VeteranHQ evaluates your symptoms against the exact 38 CFR criteria, identifies secondary conditions, and shows what evidence you need to support a higher rating.
Discover Your Benefits